Increasing Autonomous Motivation in ESRD to Enhance Phosphate Binder Adherence



Status:Completed
Conditions:Renal Impairment / Chronic Kidney Disease, Renal Impairment / Chronic Kidney Disease
Therapuetic Areas:Nephrology / Urology
Healthy:No
Age Range:18 - Any
Updated:7/11/2015
Start Date:September 2014
End Date:December 2015
Contact:Ebele M Umeukeje, MD
Email:ebele.m.umeukeje@vanderbilt.edu
Phone:615-343-6105

Use our guide to learn which trials are right for you!

Hyperphosphatemia in end-stage renal disease (ESRD) patients is a non-traditional risk
factor for all-cause and cardiovascular mortality. Non-adherence to phosphate binders is as
high as 74% in ESRD patients and has been shown to be most related to psychosocial factors
including attitudes. There is limited data on the influence of attitudes and perceived
autonomy support on phosphate binder adherence and these two psychosocial constructs can be
positively influenced through the use of motivational interviewing skills to increase
autonomous motivation. Furthermore, racial disparities are known to exist in ESRD however
and there are still gaps, which exist in understanding the determinants of disparities in
adherence in vulnerable patients with ESRD.

In this study, the investigators seek to determine the impact of motivational interviewing
on phosphate binder adherence in diverse ESRD patients. The investigators will ask all the
subjects to fill out surveys mainly regarding their attitudes; perceived providers' autonomy
support and phosphate binder adherence. The investigators will administer motivational
counseling to subjects in the intervention arm of the study, at baseline and 1 month after
recruitment. The investigators will ask all the subjects to fill out the same surveys 2
months after recruitment and the investigators will compare subjects who underwent
motivational interviewing to those who did not.


Inclusion Criteria:

- Adults age 18 years or older

- Receiving phosphate binder therapy currently

- English speaking

Exclusion Criteria:

- Non- English speaking

- Known diagnosis of psychosis or dementia, limiting ability to provide informed
consent

- Any medical condition that precludes participation in the study including deafness,
dying etc.

- Initial Morisky Medication Adherence score greater than 6
We found this trial at
1
site
1211 Medical Center Dr
Nashville, Tennessee 37232
(615) 322-5000
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
?
mi
from
Nashville, TN
Click here to add this to my saved trials